Dalrymple, Ashley N.
Jones, Sonny T.
Fallon, James B.
Shepherd, Robert K.
Weber, Douglas J.
Article History
Received: 18 December 2024
Accepted: 6 February 2025
First Online: 14 March 2025
Declarations
:
: Not applicable.
: Not applicable.
: DJW is a founder and shareholder of Reach Neuro, Inc., consultant and shareholder of Neuronoff, Inc., shareholder and scientific board member for NeuroOne Medical, Inc., and a shareholder of Bionic Power Inc., Iota Biosciences Inc., and Blackfynn Inc. JBF is Chair of the Scientific Board of Hemidemia, but does not have a financial interest. The other authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.